A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro

TFEB (transcription factor EB), which is a master regulator of autophagy and lysosome biogenesis, is considered to be a new therapeutic target for Parkinson’s disease (PD). However, only several small-molecule TFEB activators have been discovered and their neuroprotective effects in PD are unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ziying, Yang, Chuanbin, Liu, Jia, Chun-Kit Tong, Benjamin, Zhu, Zhou, Malampati, Sandeep, Gopalkrishnashetty Sreenivasmurthy, Sravan, Cheung, King-Ho, Iyaswamy, Ashok, Su, Chengfu, Lu, Jiahong, Song, Juxian, Li, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073207/
https://www.ncbi.nlm.nih.gov/pubmed/32098449
http://dx.doi.org/10.3390/ijms21041515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7073207/
https://www.ncbi.nlm.nih.gov/pubmed/32098449
http://dx.doi.org/10.3390/ijms21041515

Ejemplares similares